Drug Testing Locations - Murray, UT

Drug Testing in Murray, UT

Murray, Utah Statistics

Salt Lake County reported a 12% increase in opioid-related overdoses in the past year.

Murray saw a 38% rise in admissions for drug treatment services in the recent survey.

The rate of drug-related crimes in Murray, UT has increased by 20% over the last three years.

Salt Lake County ranks among the top 5 counties in Utah for methamphetamine-related incidents.

Emergency room visits due to drug complications have risen by 25% in Murray in the past two years.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Murray, UT & Drug Testing Policies

Employers in Murray, UT typically implement drug testing policies to ensure a safe workplace. Policies often include pre-employment screening and random tests. Organizations may align with guidelines set by the U.S. Department of Labor.

Many companies also offer Employee Assistance Programs (EAPs) providing confidential counseling services to employees dealing with substance-related issues, following best practices outlined by the Substance Abuse and Mental Health Services Administration.

Government Efforts with Drug Problems in Murray, UT

The government has initiated various programs in Murray, UT to tackle drug abuse, with a focus on prevention and support. Collaborative efforts with the Utah Department of Health aim to enhance community awareness and education on substance use.

Additionally, the establishment of the Opioid and Overdose Task Force seeks to reduce overdoses through targeted intervention strategies and better access to treatment options.

Local Drug Busts & News in Murray, UT

In recent months, Murray, UT, has seen an increase in drug-related activities, prompting local law enforcement to take decisive action. Most notably, a substantial bust involving multiple kilograms of illegal narcotics occurred last month in a quiet residential area. This operation was the result of a three-month-long investigation, highlighting the dedication of the local police department to curb drug trafficking and maintain community safety.

The Murray Police Department has increased its collaboration with neighboring cities to tackle the drug problem more effectively. Joint task forces have been organized to ensure swift response times and comprehensive investigations. These efforts have led to a series of smaller arrests that have disrupted several drug distribution networks, significantly impacting the local drug trade landscape.

Community involvement plays a crucial role in the city's fight against drugs. Recent workshops in Murray have focused on educating residents about identifying and reporting suspicious activities. The implementation of a neighborhood watch program has also shown promising results, with several leads provided by vigilant citizens that have aided police in recent investigations and arrests.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Murray, UT. Trusted by employers nationwide for accurate results and exceptional service.

Utah DOT/Non DOT Physicals

Utah Vision Tests

Utah Audiograms

Utah Respirator Fit Tests

Utah Lift Tests

Utah Background Checks

Clinical Testing Services

TB Testing in UT

Diabetes Testing in UT

Infectious Disease Testing in UT

Sickle Cell Anemia Testing in UT

Women/Men's Health Testing in UT

Resources & Citations

Utah Department of Human Services

Utah Division of Substance Abuse and Mental Health

Utah n-drug

Find Treatment

Utah Addiction Vocation Center

Substance Abuse and Mental Health Services Administration

Salt Lake County Health Department

Utah o-drug Overdose Coalition

Drug Testing Near Murray, UT

Sandy, UT

Cottonwood Heights, UT

West Jordan, UT

Canyon Rim, UT

Midvale, UT

East Millcreek, UT

Holladay, UT

Union, UT

Taylorsville, UT

Cottonwood West, UT

Millcreek, UT

Frequently Asked Questions

Customer Reviews